Suppliers / Seripharm

Seripharm

France Updated 9 July 2026

Seripharm is an API manufacturer based in France. It holds one active US drug master file. Its GMP standing is certified by ANSM (FR). Its most recent recorded inspection, by US FDA, closed on 12 March 2021 as NAI.

1
active US DMFs
0
valid CEPs
2
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
5 of 5 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 12 March 2021 NAI US FDA
  • 15 March 2018 VAI US FDA
  • 6 May 2016 NAI US FDA
  • 6 June 2013 VAI US FDA
  • 29 January 2010 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
France, France 3002808119
LE MANS, France Not on file

What they file, and where

Molecule Regulators Docs
Paclitaxel US FDA 1

Also appears on these molecule pages

Paclitaxel API

Filings and GMP by regulator

Regulator Filings GMP certificates
ANSM (FR) None 4

Questions about Seripharm

Does Seripharm hold a US DMF or a CEP?
Seripharm holds 1 active US drug master file. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Seripharm FDA-registered?
One site operated by Seripharm carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Seripharm's last inspection go?
The most recent inspection on record closed on 12 March 2021 as NAI (No Action Indicated: nothing objectionable was found). 5 inspections are on file.
Where does Seripharm manufacture?
2 registered sites are on record, in France (France and LE Mans). Every site is listed on this page with the register it came from.
What does Seripharm make?
1 molecule is on record against Seripharm, including Paclitaxel. Each links through to that molecule's full manufacturer list.
Which regulators recognise Seripharm's GMP?
Current GMP certificates are on record from ANSM (FR). GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Seripharm comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was NAI, on 12 March 2021.

Comparable suppliers

MSN Laboratories shares 1 molecule Apitoria Pharma shares 1 molecule Hetero shares 1 molecule ScinoPharm Taiwan shares 1 molecule Fresenius Kabi shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates